• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素样生长因子两种受体在人恶性胶质瘤中的表达

Expression of two types of receptor for insulin-like growth factors in human malignant glioma.

作者信息

Gammeltoft S, Ballotti R, Kowalski A, Westermark B, Van Obberghen E

机构信息

Department of Clinical Chemistry, Bispebjerg Hospital, Copenhagen, Denmark.

出版信息

Cancer Res. 1988 Mar 1;48(5):1233-7.

PMID:2963688
Abstract

Two types of receptors for insulin-like growth factors (IGFs) were characterized in glioma cell lines established from different human brain tumors of glial origin (astrocytoma grades III and IV) by competitive binding assay, affinity labeling, and protein phosphorylation. Type I IGF receptor is a heterodimer composed of alpha-subunits (Mr 130,000), which bind IGF I and II with equal affinity, and of beta-subunits (Mr 98,000), which show tyrosine kinase activity and autophosphorylation stimulated by IGF I and II with equal potency. The type II IGF binding site is a monomer (Mr 250,000) which binds IGF II with 10 times higher affinity than IGF I. The cellular concentration of type II IGF binding site is about 2- to 5-fold higher than the amount of type I IGF receptor. The characteristics of the two types of IGF receptors in human glioma cell lines are similar to those described recently in fetal rat astrocytes. In contrast the type I IGF receptor in glioma cells is different from that studied previously in normal adult brain regarding the equal affinity for IGF I and II, and the higher molecular size of the alpha-subunit (130,000 versus 115,000). It is suggested that glioma cells may represent a fetal cell type in tumor development of adult human brain. A role of IGF in malignant glioma has not yet been determined, but the presence of IGF receptors is a prerequisite for cellular actions of IGF.

摘要

通过竞争性结合试验、亲和标记和蛋白质磷酸化,在源自不同人类胶质源性脑肿瘤(III级和IV级星形细胞瘤)的胶质瘤细胞系中鉴定出两种胰岛素样生长因子(IGF)受体。I型IGF受体是一种异二聚体,由α亚基(分子量130,000)和β亚基(分子量98,000)组成,α亚基以相同亲和力结合IGF I和II,β亚基具有酪氨酸激酶活性,且受IGF I和II刺激时具有同等效力的自磷酸化作用。II型IGF结合位点是一种单体(分子量250,000),其结合IGF II的亲和力比IGF I高10倍。II型IGF结合位点的细胞浓度比I型IGF受体的量高约2至5倍。人类胶质瘤细胞系中这两种IGF受体的特征与最近在胎鼠星形胶质细胞中描述的特征相似。相比之下,胶质瘤细胞中的I型IGF受体在对IGF I和II的同等亲和力以及α亚基更高的分子大小(130,000对115,000)方面与先前在正常成人大脑中研究的不同。有人提出,在成人脑肿瘤发生过程中,胶质瘤细胞可能代表一种胎儿细胞类型。IGF在恶性胶质瘤中的作用尚未确定,但IGF受体的存在是IGF细胞作用的先决条件。

相似文献

1
Expression of two types of receptor for insulin-like growth factors in human malignant glioma.胰岛素样生长因子两种受体在人恶性胶质瘤中的表达
Cancer Res. 1988 Mar 1;48(5):1233-7.
2
Receptors for insulin-like growth factors in the central nervous system: structure and function.中枢神经系统中胰岛素样生长因子的受体:结构与功能
Horm Metab Res. 1988 Jul;20(7):436-42. doi: 10.1055/s-2007-1010854.
3
Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs).胰岛素样生长因子(IGF)与人类成纤维细胞和胶质母细胞瘤细胞的结合:细胞释放的胰岛素样生长因子结合蛋白(IGFBPs)的调节作用。
J Cell Physiol. 1990 Aug;144(2):244-53. doi: 10.1002/jcp.1041440210.
4
Demonstration of type I and type II somatomedin receptors on bovine growth plate chondrocytes.牛生长板软骨细胞上I型和II型生长调节素受体的证实
J Orthop Res. 1988;6(6):817-26. doi: 10.1002/jor.1100060605.
5
Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.膜结合型和分泌型胰岛素样生长因子结合蛋白-2在肺癌中胰岛素样生长因子作用调控中的作用
Cancer Res. 1993 Oct 1;53(19):4680-5.
6
Insulin-like growth factor receptor expression and function in human breast cancer.胰岛素样生长因子受体在人类乳腺癌中的表达与功能
Cancer Res. 1990 Jan 1;50(1):48-53.
7
Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.源自兔慢速和快速骨骼肌的卫星成肌细胞表型并不涉及胰岛素样生长因子系统各组分的组成性差异。
J Cell Physiol. 1996 Nov;169(2):227-34. doi: 10.1002/(SICI)1097-4652(199611)169:2<227::AID-JCP1>3.0.CO;2-Q.
8
Insulin-like growth factor-I receptors in human glial tumors.人类胶质肿瘤中的胰岛素样生长因子-I受体
J Clin Endocrinol Metab. 1990 Jul;71(1):199-209. doi: 10.1210/jcem-71-1-199.
9
Insulin-like growth factor II binding and action in human fetal fibroblasts.胰岛素样生长因子II在人胎儿成纤维细胞中的结合与作用
J Cell Physiol. 1987 Dec;133(3):560-6. doi: 10.1002/jcp.1041330318.
10
Insulin-like growth factor I receptors in normal and neoplastic human endometrium.正常及肿瘤性人类子宫内膜中的胰岛素样生长因子I受体
Cancer Res. 1990 May 15;50(10):3019-24.

引用本文的文献

1
MN1 overexpression with varying tumor grade is a promising predictor of survival of glioma patients.MN1 过表达与不同肿瘤分级相关,是预测胶质瘤患者生存的有前景的指标。
Hum Mol Genet. 2021 Jan 6;29(21):3532-3545. doi: 10.1093/hmg/ddaa231.
2
Glioma Cells With Genetically Engineered IGF-I Receptor Downregulation Can Persist in the Brain in a Dormant State.基因工程下调胰岛素样生长因子-I受体的胶质瘤细胞可在脑内以休眠状态持续存在。
Front Oncol. 2020 Sep 23;10:555945. doi: 10.3389/fonc.2020.555945. eCollection 2020.
3
Type 1 IGF Receptor Localization in Paediatric Gliomas: Significant Association with WHO Grading and Clinical Outcome.
1 型胰岛素样生长因子受体在小儿脑胶质瘤中的定位:与 WHO 分级和临床结果显著相关。
Horm Cancer. 2018 Jun;9(3):205-214. doi: 10.1007/s12672-018-0328-7. Epub 2018 Mar 9.
4
The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-).表皮生长因子受体通过调节氨基酸转运系统xc(-)促进胶质瘤的恶性潜能。
Cancer Res. 2016 May 15;76(10):2954-63. doi: 10.1158/0008-5472.CAN-15-2121. Epub 2016 Mar 15.
5
PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas.PID1(NYGGF4),一种在胚胎性脑肿瘤和神经胶质瘤中发现的新型生长抑制基因。
Clin Cancer Res. 2014 Feb 15;20(4):827-36. doi: 10.1158/1078-0432.CCR-13-2053. Epub 2013 Dec 3.
6
Innovative Therapies against Human Glioblastoma Multiforme.针对多形性胶质母细胞瘤的创新疗法
ISRN Oncol. 2011;2011:787490. doi: 10.5402/2011/787490. Epub 2011 Jul 24.
7
A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo.小分子 IAP 抑制剂在体外和体内克服了恶性神经胶质瘤对细胞毒疗法的耐药性。
Neuro Oncol. 2011 Aug;13(8):820-9. doi: 10.1093/neuonc/nor066. Epub 2011 Jul 1.
8
Drug or vaccine?: selecting the appropriate treatment for malignant glioma patients.药物还是疫苗?:选择合适的治疗方法治疗恶性脑胶质瘤患者。
Drugs. 2010 Aug 20;70(12):1477-86. doi: 10.2165/11538040-000000000-00000.
9
Helianthin induces antiproliferative effect on human glioblastoma cells in vitro.百合素在体外诱导人神经胶质瘤细胞的增殖抑制作用。
J Neurooncol. 2011 Mar;102(1):9-18. doi: 10.1007/s11060-010-0285-7. Epub 2010 Jul 16.
10
Glioma pathophysiology: insights emerging from proteomics.胶质瘤病理生理学:蛋白质组学带来的新见解
Brain Pathol. 2010 Jul;20(4):691-703. doi: 10.1111/j.1750-3639.2010.00376.x. Epub 2010 Jan 13.